Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9

...

CNBC Daily Open: 'Crazy' summer

August 20, 2024

Wednesday's big stock stories: What's likely to move the market in the next trading session

August 20, 2024

Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial

August 20, 2024

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

August 15, 2024

Thursday's big stock stories: What’s likely to move the market in the next trading session

August 14, 2024

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

August 14, 2024

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

August 13, 2024

After Eli Lilly's blowout quarter, Cramer says not to get too caught up in macro market trends

August 08, 2024

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

August 08, 2024

Thursday's big stock stories: What's likely to move the market in the next trading session

August 07, 2024

5 things to know before the stock market opens Monday

August 05, 2024

Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says

August 02, 2024

Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study

August 01, 2024

Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes

July 31, 2024

Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says

July 30, 2024

Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data

July 29, 2024

European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai

July 26, 2024

Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial

July 25, 2024

Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell

July 18, 2024

CNBC Daily Open: Rising geopolitical risk

July 18, 2024

CNBC Daily Open: Rising geopolitical risk

July 17, 2024

Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche

July 17, 2024

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

July 16, 2024

Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills

July 11, 2024

Pfizer moves forward with once-daily version of weight loss pill after setbacks

July 11, 2024

Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'

July 10, 2024

Jim Cramer reviews 8 companies that could top $1 trillion in market cap

July 10, 2024

FTC to sue drug middlemen over prices of medications including insulin

July 10, 2024

Companies besides tech can reach megacap status, Jim Cramer says

July 08, 2024

This ETF is trying to satisfy appetites for weight loss stocks

July 06, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.